高级检索

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

非药物干预措施对呼吸道病毒感染影响研究进展

杜卓雯 姚星妹 周裕林

杜卓雯, 姚星妹, 周裕林. 非药物干预措施对呼吸道病毒感染影响研究进展[J]. 中国公共卫生. doi: 10.11847/zgggws1143645
引用本文: 杜卓雯, 姚星妹, 周裕林. 非药物干预措施对呼吸道病毒感染影响研究进展[J]. 中国公共卫生. doi: 10.11847/zgggws1143645
DU Zhuowen, YAO Xingmei, ZHOU Yulin. Effect of non-pharmaceutical interventions on respiratory tract virus infection: a review on research progress[J]. Chinese Journal of Public Health. doi: 10.11847/zgggws1143645
Citation: DU Zhuowen, YAO Xingmei, ZHOU Yulin. Effect of non-pharmaceutical interventions on respiratory tract virus infection: a review on research progress[J]. Chinese Journal of Public Health. doi: 10.11847/zgggws1143645

非药物干预措施对呼吸道病毒感染影响研究进展

doi: 10.11847/zgggws1143645
基金项目: 福建省医学创新课题(2021CXB025);厦门市科技项目(3502Z20224014);福建省临床重点专科建设项目
详细信息
    作者简介:

    杜卓雯(1999 – ),硕士在读,研究方向:儿童呼吸道感染的流行病学特征

    通信作者:

    周裕林,E-mail:zhou_yulin@126.com

Effect of non-pharmaceutical interventions on respiratory tract virus infection: a review on research progress

More Information
  • 摘要: 急性呼吸道感染主要由病毒引起,人群发病率较高,特别是在幼儿、老年人和免疫缺陷患者中。急性呼吸道感染在全球范围内保持着高发病率和高死亡率,疾病负担严重,因此,有效预防呼吸道传染性病毒的传播和流行已经成为了人们关注的全球问题之一。非药物干预措施(NPIs)是预防呼吸道病毒感染和传播的重要方式,包括个人防护、病例隔离、旅行限制等。新型冠状病毒感染大流行期间实施的非药物干预措施不仅有效减缓了SARS-CoV-2在全球范围内的传播,也对呼吸道传染性病毒的传播产生了影响。本文对常见的呼吸道病毒在非药物干预措施实施前后的流行病学特征变化及非药物干预措施对呼吸道传染性病毒传播的影响进行综述。
  • [1] Martin NG, Iro MA, Sadarangani M, et al. Hospital admissions for viral meningitis in children in England over five decades: a population-based observational study[J]. The LancetInfectious Diseases, 2016, 16(11): 1279 – 1287.
    [2] De Conto F, Conversano F, Medici MC, et al. Epidemiology of human respiratory viruses in children with acute respiratory tract infection in a 3-year hospital-based survey in Northern Italy[J]. Diagnostic Microbiology and Infectious Disease, 2019, 94(3): 260 – 267. doi: 10.1016/j.diagmicrobio.2019.01.008
    [3] GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990 – 2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. The Lancet, 2020, 396(10258): 1204 – 1222. doi: 10.1016/S0140-6736(20)30925-9
    [4] de BenedictisFM, BushA. Recurrent lower respiratory tract infec-tions in children[J]. BMJ, 2018, 362: k2698.
    [5] Dong W, Chen QQ, Hu YH, et al. Epidemiological and clinical characteristics of respiratory viral infections in children in Shanghai, China[J]. Archives of Virology, 2016, 161(7): 1907 – 1913. doi: 10.1007/s00705-016-2866-z
    [6] Oster Y, Abu Ahmad W, Michael-Gayego A, et al. Viral and bacterial respiratory pathogens during the COVID-19 pandemic in Israel[J]. Microorganisms, 2023, 11(1): 166. doi: 10.3390/microorganisms11010166
    [7] Maison N, Omony J, Rinderknecht S, et al. Old foes following news ways?-Pandemic-related changes in the epidemiology of viral respiratory tract infections[J]. Infection, 2023, doi: 10.1007/s15010-023-02085-w.
    [8] Burrell R, Saravanos G, BrittonPN. Unintended impacts of COVID-19 on the epidemiology and burden of paediatric respiratory infections[J]. Paediatric Respiratory Reviews, 2023,doi: 10.1016/j.prrv.2023.07.004.
    [9] Sarmiento Clemente A, Kaplan SL, Barson WJ, et al. Decrease in pediatric invasive pneumococcal disease during the COVID-19 pandemic[J]. Journal of the Pediatric Infectious Diseases Society, 2022, 11(9): 426 – 428. doi: 10.1093/jpids/piac056
    [10] Tamerius J, Nelson MI, Zhou SZ, et al. Global influenza seasonality: reconciling patterns across temperate and tropical regions[J]. Environmental Health Perspectives, 2011, 119(4): 439 – 445. doi: 10.1289/ehp.1002383
    [11] Principi N, Autore G, Ramundo G, et al. Epidemiology of respiratory infections during the COVID-19 pandemic[J]. Viruses, 2023, 15(5): 1160. doi: 10.3390/v15051160
    [12] 王颖硕. 儿童呼吸道病毒感染的流行病学特点[J]. 中国实用儿科杂志, 2019, 34(2): 100 – 104. doi: 10.19538/j.ek2019020609
    [13] Li Y, Reeves RM, Wang X, et al. Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parain-fluenza virus, and metapneumovirus: a systematic analysis[J]. The Lancet Global Health, 2019, 7(8): e1031 – e1045. doi: 10.1016/S2214-109X(19)30264-5
    [14] 雷娜, 高文慧, 李丽. 中国2018 – 2022年哨点医院流感样病例流感病毒监测[J]. 中国疫苗和免疫, 2023, 29(4): 436 – 441.
    [15] Li Y, Wang X, Blau DM, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis[J]. TheLancet, 2022, 399(10340): 2047 – 2064.
    [16] Kenmoe S, Bigna JJ, Well EA, et al. Prevalence of human respiratory syncytial virus infection in people with acute respiratory tract infections in Africa: a systematic review and meta-analysis[J]. Influenza and Other Respiratory Viruses, 2018, 12(6): 793 – 803. doi: 10.1111/irv.12584
    [17] Yao Y, Zhao ZP, Song WQ, et al. Unreliable usage of a single influenza virus IgM antibody assay in influenza-like illness: a retrospective study of the 2016 – 2018 flu epidemic[J]. PLoS One, 2019, 14(4): e0215514. doi: 10.1371/journal.pone.0215514
    [18] World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 – 11 March 2020[R]. Geneva: WHO, 2020.
    [19] World Health Organization. Coronavirus disease (COVID-2019) situation reports[R]. Geneva: World Health Organization, 2020.
    [20] Flaxman S, Mishra S, Gandy A, et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 inEurope[J]. Nature, 2020, 584(7820): 257 – 261. doi: 10.1038/s41586-020-2405-7
    [21] Askitas N, Tatsiramos K, Verheyden B. Estimating worldwide effects of non-pharmaceutical interventions on COVID-19 incidence and population mobility patterns using a multiple-event study[J]. Scientific Reports, 2021, 11(1): 1972. doi: 10.1038/s41598-021-81442-x
    [22] Chow EJ, Uyeki TM, Chu HY. The effects of the COVID-19 pandemic on community respiratory virus activity[J]. Nature Reviews Microbiology, 2023, 21(3): 195 – 210.
    [23] Seattle Flu Alliance. Pathogens[EB/OL].(2022). https://seattleflu.org/pathogens.
    [24] Feng LZ, Zhang T, Wang Q, et al. Impact of COVID-19 outbreaks and interventions on influenza in China and the United States[J].Nature Communications, 2021, 12(1): 3249.
    [25] Merced-Morales A, Daly P, AbdElal AI, et al. Influenza activity and composition of the 2022 – 23 influenza vaccine - United States, 2021 – 22 season[J]. Morbidity and Mortality Weekly Report, 2022, 71(29): 913 – 919. doi: 10.15585/mmwr.mm7129a1
    [26] Groves HE, Piché-Renaud PP, Peci A, et al. The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada: a population-based study[J]. The Lancet RegionalHealth-Americas, 2021, 1: 100015. doi: 10.1016/j.lana.2021.100015
    [27] Eisen AKA, Gularte JS, Demoliner M, et al. Low circulation of Influenza A and coinfection with SARS-CoV-2 among other respiratory viruses during the COVID-19 pandemic in a region of southern Brazil[J]. Journal of Medical Virology, 2021, 93(7): 4392 – 4398. doi: 10.1002/jmv.26975
    [28] Zhang XX, Du J, Li G, et al. Assessing the impact of COVID-19 interventions on influenza-like illness in Beijing and Hong Kong: an observational and modeling study[J]. Infectious Diseases of Poverty, 2023, 12(1): 11. doi: 10.1186/s40249-023-01061-8
    [29] Burns AAC, Gutfraind A. Effectiveness of isolation policies inschools: evidence from a mathematical model of influenza andCOVID-19[J]. PeerJ, 2021, 9: e11211.
    [30] Yeoh DK , Foley DA, Minney-Smith CA, et al. Impact of coronavirus disease 2019 public health measures on detections of influenza and respiratory syncytial virus in children during the 2020 Australian winter[J]. Clinical Infectious Diseases, 2021, 72(12): 2199 – 2202. doi: 10.1093/cid/ciaa1475
    [31] Abo YN, Clifford V, Lee LY, et al. COVID-19 public health measures and respiratory viruses in children in Melbourne[J]. Journal of Paediatricsand Child Health, 2021, 57(12): 1886 – 1892. doi: 10.1111/jpc.15601
    [32] Britton PN, Hu N, Saravanos G, et al. COVID-19 public health measures and respiratory syncytial virus[J]. The Lancet Child andAdolescent Health, 2020, 4(11): e42 – e43. doi: 10.1016/S2352-4642(20)30307-2
    [33] Bardsley M, Morbey RA, Hughes HE, et al. Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study[J]. The LancetInfectious Diseases, 2023, 23(1): 56 – 66.
    [34] Wang HP, Zheng YJ, de Jonge MI, et al. Lockdown measures during the COVID-19 pandemic strongly impacted the circulation of respiratory pathogens in Southern China[J]. Scientific Reports, 2022, 12(1): 16926. doi: 10.1038/s41598-022-21430-x
    [35] Casalegno JS, Ploin D, Cantais A, et al. Characteristics of the delayed respiratory syncytial virus epidemic, 2020/2021, Rhône Loire, France[J]. Eurosurveillance, 2021, 26(29): 2100630.
    [36] Cohen R, Ashman M, Taha MK, et al. Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap?[J]. Infectious Diseases Now, 2021, 51(5): 418 – 423. doi: 10.1016/j.idnow.2021.05.004
    [37] Hönemann M, Thiem S, Bergs S, et al. In-depth analysis of the re-emergence of respiratory syncytial virus at a tertiary care hospital in Germany in the summer of 2021 after the alleviation of non-pharmaceutical interventions due to the SARS-CoV-2 pandemic[J]. Viruses, 2023, 15(4): 877. doi: 10.3390/v15040877
    [38] Cooksey GLS, Morales C, Linde L, et al. Severe acute respiratory syndrome coronavirus 2 and respiratory virus sentinel surveillance, California, USA, May 10, 2020 – June 12, 2021[J]. Emerging Infectious Diseases, 2022, 28(1): 9 – 19. doi: 10.3201/eid2801.211682
    [39] Olsen SJ, Winn AK, Budd AP, et al. Changes in influenza and other respiratory virus activity during the COVID-19 pandemic – United States, 2020 – 2021[J]. Morbidity and Mortality Weekly Report, 2021, 70(29): 1013 – 1019. doi: 10.15585/mmwr.mm7029a1
    [40] Liu PC, Xu MH, Cao LF, et al. Impact of COVID-19 pandemic on the prevalence of respiratory viruses in children with lower respiratory tract infections in China[J]. Virology Journal, 2021, 18(1): 159. doi: 10.1186/s12985-021-01627-8
    [41] Firquet S, Beaujard S, Lobert PE, et al. Survival of enveloped and non-enveloped viruses on inanimate surfaces[J]. Microbes and Environments, 2015, 30(2): 140 – 144. doi: 10.1264/jsme2.ME14145
    [42] 中华人民共和国国家卫生健康委员会. 国家卫生健康委员会2023年11月26日新闻发布会文字实录[EB/OL]. (2023 – 11 – 26). http://www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=07f534629af6437cbfd53b26300c334c
    [43] 疾病预防控制局. 传染病预防控制[EB/OL]. http://www.nhc.gov.cn/jkj/s2907/new_list_7.shtml
  • 加载中
计量
  • 文章访问数:  370
  • HTML全文浏览量:  130
  • PDF下载量:  112
  • 被引次数: 0
出版历程
  • 接收日期:  2023-11-24
  • 录用日期:  2023-12-04
  • 修回日期:  2023-11-29
  • 网络出版日期:  2023-12-05

目录

    /

    返回文章
    返回